Pharma Will Need To Embrace More Inward-Looking China

Policies To Affect Market Access?

The world’s second-largest economy is fast moving away from reforms and open to a "dual circulation" model, focusing on domestic market consumption while reducing export-driven production. Executives and investors shared views at a conference on whether multinational pharma firms are still welcome in China and what opportunities may lie in the drastic policy shift.

GreatWall
CHINA'S DUAL CIRCULATION POLICY CREATING MORE BARRIERS FOR FOREIGN PLAYERS, EXECUTIVES SAY • Source: Alamy

In China's Fourteenth Five-Year Plan for the 2020-25 period, President Xi Jinping outlined a new and bold economic policy move - moving away from a four-decade policy of fundamental reforms and opening to the idea of "dual circulation", comprising domestic consumption and international trade and investment.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from China

More from Asia